Your browser doesn't support javascript.
loading
Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria.
Badri, Prajakta; Jiang, Xuemin; Borodovsky, Anna; Najafan, Nader; Kim, Jae; Clausen, Valerie A; Goel, Varun; Habtemariam, Bahru; Robbie, Gabriel J.
Afiliação
  • Badri P; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA. pbadri@alnylam.com.
  • Jiang X; Agios Pharmaceuticals, Cambridge, MA, USA.
  • Borodovsky A; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
  • Najafan N; Alexion Pharmaceuticals, Boston, MA, USA.
  • Kim J; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
  • Clausen VA; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
  • Goel V; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
  • Habtemariam B; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
  • Robbie GJ; Clinical Pharmacology and PharmacometricsAlnylam Pharmaceuticals, 101 Main Street, Cambridge, MA, 02142, USA.
Clin Pharmacokinet ; 61(6): 919, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35579826

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos